The lawsuit was filed under the False Claims Act, which helps the government combat fraud and requires tripling of damages, which inflated CVS’s penalty. The company argues the Constitution bars ...

Humana Inc (NYSE:HUM) stock fell as much as 7.5% before trimming losses to 4% following a court ruling against the health insurer in its Medicare bonus payment lawsuit. The decision also impacted ...

CVS Health (NYSE:CVS) shares extended six straight sessions of losses, as the stock slipped 0.7% at $63.38 on Thursday. The ...

CVS Health plans to appeal after a judge in the Southern District of New York ordered its Omnicare unit to pay more than $948 million in penalties and damages related to invalid prescriptions.

CVS has vowed to appeal $948.8 million in fines and damages imposed by a judge Tuesday on its Omnicare unit, for billing Medicare for tens of thousands of false claims.

From a CVS subsidiary ordered to pay nearly $950 million in a false claims case to the Supreme Court upholding the ACA’s preventive coverage mandate, here are 12 healthcare industry lawsuits, ...

UnitedHealth Group is under criminal and civil investigation by the DOJ over alleged Medicare fraud, raising serious ...

Currently, a multidistrict litigation against Pfizer (NYSE: PFE) is underway on behalf of women who claim to have developed meningiomas after receiving four or more consecutive injections of ...

A class action suit brought by Meta shareholders that sought $8 billion from its current and former leaders has been settled. The suit was filed as recompense for the $5 billion in fines and added ...

A bill introduced by Rep. Earl L. "Buddy" Carter would ban PBMs’ use of spread pricing in Medicaid, among other reforms.

Anesthesia providers are grappling with a variety of legislative and policy-related issues that hold implications for patient access, provider compensation and practice staffing. Here are four recent ...

While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...